Cardiovascular Systems Inc Revenue per Employee (CSII), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cardiovascular Systems Inc   (NASDAQ: CSII)
 

Cardiovascular Systems Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 3.92% in the second quarter 2023, year on year to cumulative value of $240 million, Cardiovascular Systems Inc 's revenue per employee grew on a trailing twelve months basis to $ 479,686. The productivity of Cardiovascular Systems Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 258 other companies have achieved higher revenue per employee. While Cardiovascular Systems Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 2381. Cardiovascular Systems Inc has 500 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CSII Revenue per Employee (Dec 31 2022)
II. Quarter		 (Sep 30 2022)
I. Quarter		 (Jun 30 2022)
IV. Quarter		 (Mar 31 2022)
III. Quarter		 (Dec 31 2021)
II. Quarter
Y / Y Revenue Change 3.92 % 2.23 % -11.96 % -11.15 % -7.84 %
Sales per Employee (TTM) $ 479,686 475,050 472,444 489,426 503,530
CSII's Total Ranking # 2381 # 0 # 0 # 0 # 0
Seq. Revenue Change 2.98 % -4.52 % 11.16 % -4.93 % 1.31 %

CSII Company Profile >> Back to CSII Efficiency Comparisons >> Compare CSII Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 66
Healthcare Sector # 259
Overall Market # 2381

Revenue per Employee Statistics
High Average Low
$ 264,369 $ 218,207 $ 148,200
(Dec 31 2019)   (Sep. 30, 2014)



Financial Statements
Cardiovascular Systems Inc 's Revenue MRQ $ 61 Millions Visit CSII's Income Statement
Cardiovascular Systems Inc 's Revenues TTM $ 240 Millions Visit CSII's aggregate revenue growth
What are CSII's Sales? Visit CSII's Sales by Segment




Other Ratios
Cardiovascular Systems Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CSII's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CSII's Competitors
Revenue per Employee for CSII's Suppliers
Revenue per Employee for CSII's Customers

You may also want to know
CSII's Sales Growth Rates CSII's Pe Price to earnings ratio CSII's Receivables Turnover Ratio CSII's Stock Quote
CSII's Net Income Growth Rates CSII's Ps Price to Sales ratio CSII's Sales per Employee CSII's Asset Turnover Ratio
CSII's Net Margin CSII's Pb Price to Book ratio CSII's Financial Strength Ratios CSII's Dividend Payout Ratio
Date modified: 2026-06-22T14:32:26+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2022Number of Employees Dec 31 2022
Prothena Corporation Public Limited Company  804,552.24 $ 53.905  Million 67 
Pacira Biosciences inc   804,370.33 $ 666.823  Million 829 
Biofrontera Inc   801,478.26 $ 73.736  Million 92 
Endo International Plc  791,154.90 $ 2,318.875  Million 2,931 
Merck and Co Inc   790,440.00 $ 59,283.000  Million 75,000 
Regeneron Pharmaceuticals Inc   789,935.11 $ 12,172.900  Million 15,410 
Prenetics Global Limited  787,889.42 $ 275.761  Million 350 
Sangamo Therapeutics Inc   783,795.77 $ 111.299  Million 142 
Lantheus Holdings Inc   783,789.61 $ 935.061  Million 1,193 
Orasure Technologies Inc  774,958.00 $ 387.479  Million 500 
Cytomx Therapeutics Inc   770,478.26 $ 53.163  Million 69 
Argenx Se  745,655.92 $ 856.013  Million 1,148 
Neurocrine Biosciences Inc   744,350.00 $ 1,488.700  Million 2,000 
Sensus Healthcare Inc   742,200.00 $ 44.532  Million 60 
Ptc Therapeutics inc   705,147.33 $ 698.801  Million 991 
Rigel Pharmaceuticals Inc  691,045.98 $ 120.242  Million 174 
Phenomex Inc   689,429.82 $ 78.595  Million 114 
Karyopharm Therapeutics Inc   688,921.05 $ 157.074  Million 228 
Novartis Ag  688,588.62 $ 51,828.000  Million 75,267 
Assure Holdings Corp   686,000.00 $ 10.976  Million 16 
Luna Innovations Inc  684,356.25 $ 109.497  Million 160 
Enanta Pharmaceuticals Inc  684,141.67 $ 82.097  Million 120 
Inventiva S a   682,024.00 $ 13.640  Million 20 
The Oncology Institute Inc   676,352.57 $ 433.542  Million 641 
Cti Biopharma Corp   674,350.00 $ 53.948  Million 80 
Johnson and Johnson  674,311.08 $ 94,943.000  Million 140,800 
Cardiff Lexington Corporation  666,570.72 $ 11.998  Million 18 
Whitehawk Therapeutics Inc   661,565.22 $ 15.216  Million 23 
Y mabs Therapeutics inc   652,670.00 $ 65.267  Million 100 
Biomarin Pharmaceutical Inc  650,741.70 $ 2,096.039  Million 3,221 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.